Clinical Study Results
The chart below shows the treatments the participants took:
BGF MDI, containing: 2 puffs, twice a day
• 320 µg of budesonide
• 14.4 µg of glycopyrronium
• 9.6 µg of formoterol
fumarate
GFF MDI, containing: 2 puffs, twice a day
• 14.4 µg of glycopyrronium
• 9.6 µg of formoterol
fumarate
Atrovent HFA 2 puffs, 4 times a day:
• 7 to 14 days before the
start of the study
• in between taking the two
study treatments
Ventolin HFA As needed
What happened during the study?
The participants were in the study for nearly 4 months. But the entire study took 10
months to finish.
The study started in February 2019 and ended in November 2019.
5